SCHEMBL13048752

SCHEMBL13048752

CC1(C)Oc2ccc(Nc3nc(NC4CC4)c4c(S(C)(=O)=O)n[nH]c4n3)nc2NC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 6/20 0.41
ADORA3 P0DMS8 2/20 0.41
TYRO3 Q06418 2/20 0.41
JAK1 P23458 2/20 0.41
JAK3 P52333 2/20 0.41
PIK3CD O00329 2/20 0.41
MAP4K1 Q92918 2/20 0.41
CDK7 P50613 2/20 0.41
BMPR1B O00238 1/20 0.41
CDC7 O00311 1/20 0.41
PLK4 O00444 1/20 0.41
STK25 O00506 1/20 0.41
CIT O14578 1/20 0.41
RIOK3 O14730 1/20 0.41
CHEK1 O14757 1/20 0.41
IKBKB O14920 1/20 0.41
AURKA O14965 1/20 0.41
GAK O14976 1/20 0.41
CHUK O15111 1/20 0.41
MUSK O15146 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3709330 0.76 SYK (0.52) SYKADORA3TYRO3JAK1JAK3
SCHEMBL12085276 0.76 PAK4 (0.43) SYKADORA3TYRO3JAK1JAK3
SCHEMBL13048626 0.72 SYK (0.45) SYKTYRO3JAK1JAK3PIK3CD
SCHEMBL13048256 0.72 SYK (0.45) SYKTYRO3JAK1JAK3PIK3CD
SCHEMBL13048712 0.71 MEN1 (0.44) SYKADORA3TYRO3PIK3CDCDK7
SCHEMBL13048601 0.71 MERTK (0.53) SYKTYRO3JAK3AURKAJAK2
SCHEMBL13048163 0.71 ADORA3 (0.50) SYKADORA3TYRO3JAK3PIK3CD
SCHEMBL13048365 0.71 SYK (0.51) SYKTYRO3JAK1JAK3CDK7
SCHEMBL13048161 0.71 SYK (0.54) SYKCDK7CDK1IGF1RCDK2
SCHEMBL13048621 0.70 SYK (0.48) SYKPIK3CDCDK1CDK2PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND SYK, LCK, FYN SYK 1/4885ADORA3 3474/4885TYRO3 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.